Jennifer Chien Email

EVP, Head North America . Rhythm Pharmaceuticals

Current Roles

Employees:
300
Revenue:
$5.9M
About
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm's lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals Address
222 Berkeley Street
Boston, MA
United States

Past Companies

Rhythm Pharmaceuticals Inc.Executive Vice President, Head of North America
Krystal Biotech, Inc.Chief Commercial Officer
Sanofi GenzymeVice President, Head of Genetic Diseases, US Rare Diseases

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.